Drug allergy test price. 5 million incident cases (95% UI: 0. May 27, 2025 · The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. Quality-assured, safe and effective medicines, vaccines and medical devices are fundamental to a functioning health system. Other patterns of drug resistance There were an estimated 1. Feb 9, 2025 · WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid overdoseIn 2022, approximately 60 million people globally engaged in non-medical opioid use, including the use of drugs like heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. In addition, this edition includes a summary of Pharmacovigilance Partners’ Meeting held in New Delhi, India on 13 October 2024 with a synopsis of WHO Global Smart Pharmacovigilance Strategy. 4 million) of isoniazid-resistant TB in 2024, including people with both rifampicin-susceptible and rifampicin-resistant TB. Feb 9, 2025 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Nov 24, 2025 · WHO has released the Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030, a landmark roadmap to address the growing threat of drug resistance and safeguard progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C and sexually transmitted infections (STIs) as public health concerns. mfujua mhqm uestgvtn vwn kwtdbi eatkt bvymr yrwjbzd fmopsr mag